Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?

by Anouk T Urbanus, Marjolijn van Keep, Amy A Matser, Mark H Rozenbaum, Christine J Weegink, Anneke van den Hoek, Maria Prins, Maarten J Postma
Published 2013-01-01

Evaluation of persistence of resistant variants with ultra-deep pyrosequencing in chronic hepatitis C patients treated with telaprevir.

by Xiomara V Thomas, Joep de Bruijne, James C Sullivan, Tara L Kieffer, Cynthia K Y Ho, Sjoerd P Rebers, Michel de Vries, Hendrik W Reesink, Christine J Weegink, Richard Molenkamp, Janke Schinkel
Published 2012-01-01